- Home
- GNFT vs IGI Comparison
GNFT vs IGI Comparison
Compare GNFT & IGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- IGI
- Stock Information
- Founded
- GNFT 1999
- IGI 2009
- Country
- GNFT France
- IGI United States
- Employees
- GNFT N/A
- IGI N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- IGI Investment Managers
- Sector
- GNFT Health Care
- IGI Finance
- Exchange
- GNFT Nasdaq
- IGI Nasdaq
- Market Cap
- GNFT 211.1M
- IGI 190.2M
- IPO Year
- GNFT 2019
- IGI N/A
- Fundamental
- Price
- GNFT $4.34
- IGI $18.18
- Analyst Decision
- GNFT Strong Buy
- IGI
- Analyst Count
- GNFT 1
- IGI 0
- Target Price
- GNFT $13.00
- IGI N/A
- AVG Volume (30 Days)
- GNFT 4.6K
- IGI 33.9K
- Earning Date
- GNFT 09-19-2024
- IGI 01-01-0001
- Dividend Yield
- GNFT N/A
- IGI 4.79%
- EPS Growth
- GNFT N/A
- IGI N/A
- EPS
- GNFT N/A
- IGI N/A
- Revenue
- GNFT $38,115,397.00
- IGI N/A
- Revenue This Year
- GNFT $171.45
- IGI N/A
- Revenue Next Year
- GNFT N/A
- IGI N/A
- P/E Ratio
- GNFT N/A
- IGI N/A
- Revenue Growth
- GNFT 31.38
- IGI N/A
- 52 Week Low
- GNFT $2.89
- IGI $15.13
- 52 Week High
- GNFT $6.05
- IGI $17.79
- Technical
- Relative Strength Index (RSI)
- GNFT 54.93
- IGI 80.00
- Support Level
- GNFT $3.90
- IGI $17.82
- Resistance Level
- GNFT $4.45
- IGI $17.88
- Average True Range (ATR)
- GNFT 0.25
- IGI 0.14
- MACD
- GNFT 0.01
- IGI 0.01
- Stochastic Oscillator
- GNFT 80.51
- IGI 82.75
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About IGI Western Asset Investment Grade Defined Opportunity Trust Inc.
Western Asset Invstm Grd Dfnd Opp Tr Inc operates as a non-diversified closed-end management investment company. Its primary investment objective is to provide current income and then liquidate & distribute substantially all of the Fund's net assets to stockholders. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing at least 80% of its net assets in investment-grade corporate fixed-income securities of varying maturities.